People who are in need of weight loss medications but do not have insurance coverage will soon have a new way to access one of the popular medications, Zepbound.
Eli Lilly, the maker of Zepbound, announced Tuesday it will begin selling the weight loss drug directly to consumers through the company’s direct pharmacy, LillyDirect.
With a doctors’ prescription, consumers will be able to purchase Zepbound in vial forms that are about half the price of the auto-injector pre-filled pens sold in pharmacies, according to Eli Lilly CEO Dave Ricks.
A one-month supply of Zepbound at a 2.5-milligram dose will cost $399, while a one-month supply at a 5-milligram dose will cost $549, according to Ricks.
“It’s an exciting day for people who’ve been looking for a way to access and afford our weight loss medication Zepbound,” Ricks told ABC News’ Whit Johnson in an interview that aired Tuesday on “Good …